Daewon Pharmaceutical at AAPS 2026 PharmSci 360
Oct 25–28, 2026 New Orleans, LA ~4k attendees Website
Daewon Pharmaceutical brings 2 presentations to AAPS 2026 PharmSci 360 in New Orleans. Daewon Pharmaceutical's program spans oral peptide formulation and excipient testing. Its work covers stopping medium-chain fatty acids from clumping in acid to help oral semaglutide absorb, and a quick visual test plus an HPLC method for trace nitrite in common excipients.
| Organization | AAPS 2026 PharmSci 360 Attendance |
|---|---|
Daewon Pharmaceutical Seoul, South Korea | |
South Korean drug maker selling prescription and over-the-counter medicines. | Poster Mon Oct 26 2:30pm–3:30pm Inhibition of Acid-Induced MCFA Aggregation: A Formulation Strategy to Enhance Oral Semaglutide Absorption Poster Tue Oct 27 12:30pm–1:30pm Development of a Rapid, Instrument-Free Visual Limit Test and Quantitative HPLC Method for Trace Nitrite in Six Pharmaceutical Excipients |
Instantly find 20 buyers from Daewon Pharmaceutical
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Not affiliated with or endorsed by the American Association of Pharmaceutical Scientists (AAPS). Submit a correction